A randomised double blind placebo controlled Phase II study of fulvestrant with or without the addition of vandetanib as treatment for patients with metastatic breast cancer resistant to aromatase inhibitor therapy.
HealthWise Wales is a national longitudinal study, funded by the Welsh Government, aiming to recruit 50,000 people over the age of 16 either living in Wales or accessing healthcare in Wales.
Working with organisations who design and conduct trials to develop a toolkit to help researchers to implement the framework in their work and so design more inclusive trials in the future.
Using a range of participatory research methods, the research aimed to glean in-depth understandings of issues around health and wellbeing in pregnancy for women living in poverty in areas of deprivation.